Endovascular Today19h
Bentley’s BeFlared Bridging Stent for FEVAR Used in First-in-Human Procedure
Bentley InnoMed GmbH announced the first-in-human implantation of the BeFlared stent graft system, which recently received CE ...
Endovascular Today1d
IceCure’s ProSense Cryoablation System’s Benefit-Risk Profile for Breast Cancer Indications Reviewed by FDA Panel
IceCure Medical Ltd. recently announced the FDA Medical Device Advisory Committee Panel’s favorable recommendation (voti ...
Endovascular Today2d
Boston Scientific to Acquire Intera Oncology
Boston Scientific Corporation announced it has entered into a definitive agreement to acquire Intera Oncology Inc. Boston ...
Endovascular Today2d
Merit’s Wrapsody Device Evaluated in WAVE Pivotal Trial’s Arteriovenous Graft Cohort
Merit Medical Systems, Inc. announced 6-month findings from the single-arm arteriovenous graft (AVG) cohort of the WAVE pivota ...
Endovascular Today4d
Bentley’s BeGraft and BeFlared Gain TÜV Certification as Bridging Stents for FEVAR
Bentley InnoMed GmbH announced it has been granted two TÜV certificates that extend indications for its stents in complex ...
Endovascular Today13d
Healionics’ Stargraft AV Dialysis Access Device Receives FDA Breakthrough Device Designation
Healionics Corporation announced that its Stargraft arteriovenous (AV) graft for dialysis access has been granted ...
Endovascular Today13d
Arsenal Medical’s EMBO-02 Study of NeoCast Liquid Embolic for cSDH Begins in Australia
Arsenal Medical announced the initiation of the EMBO-02 clinical study of its NeoCast liquid embolic to treat chronic ...
Endovascular Today7d
Simcere’s Sanbexin Before Thrombectomy Studied to Improve Outcomes After AIS in TASTE-2
Simcere Pharmaceuticals Group Ltd. recently announced that findings from the TASTE-2 clinical study have shown that the admini ...
Endovascular Today7d
1-Year Data Presented From enVVeno’s VenoValve Pivotal Trial
November 20, 2024—enVVeno Medical Corporation announced 1-year data on all patients from SAVVE, the United States pivotal trial of the company&r ...
Endovascular Today6d
Solaris Endovascular, Inc. Launched in the United States
Solaris Endovascular, Inc. recently announced the formation of the company, which will develop solutions for dialysis access i ...
Endovascular Today13d
R3 Vascular Receives IDE Approval for ELITE-BTK Pivotal Trial of Magnitude Scaffold
R3 Vascular Inc. recently announced that the FDA granted investigational device exemption (IDE) approval to initiate the compa ...
Endovascular Today7d
Xeltis Receives FDA Breakthrough Device Designation for aXess Vascular Access Conduit, Begins US Pivotal Trial
Xeltis recently announced that the FDA has granted Breakthrough Device designation for the company’s aXess vascular acce ...